This recorded webinar explores recent advances in pharmaceutical development by introducing NGK's infrared crystal screening technology and Professor Etsuo Yonemochi's research on crystalline polymorphism and morphology.
NGK Corporation is a Japan based global materials manufacturer with more than 100 years of expertise in advanced ceramics, supporting a wide range of industries including electronics and life sciences. In the first part of this recorded webinar, NGK introduces its newly launched crystal polymorphism screening service, which applies the company's infrared radiation technology. By employing infrared radiation as a novel screening approach, the service aims to increase the likelihood of discovering previously unknown crystalline forms, thereby contributing to more robust and reliable pharmaceutical development. Several recent experimental case studies are presented to highlight the potential of this technology.
In the second part, Professor Etsuo Yonemochi (School of Pharmaceutical Sciences, Narita Campus, International University of Health and Welfare) delivers an invited lecture on pharmaceutical crystal morphology. He discusses how crystallization conditions influence crystal habit and how crystal morphology affects dissolution behavior, wettability, and manufacturability, along with examples of applying molecular simulations to evaluate formulation-related properties.
Presenters
Shozo Fukuda
Shozo Fukuda is a seasoned pharmaceutical industry leader currently spearheading global business development and international sales for NGK’s Crystal Polymorphism Screening Service.
Etsuo Yonemochi
Dr. Etsuo Yonemochi is a distinguished academic and leading authority in pharmaceutical engineering and physical chemistry with over 30 years of research experience in the field.
Sponsor
NGK Corporation
Content Partners
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.
